There are several important issues to address when choosing the starting material for a biomarker discovery study ( Table 2 ). The most important is perhaps the availability of samples of ...

QurAlis intends to advance QRL-101 into proof-of-concept studies as a potentially best-in-class treatment for both ALS and epilepsy CAMBRIDGE, Mass., March 12, 2025 /PRNewswire/ -- QurAlis ...

For years, the Alzheimer’s disease field has been on a quest for the perfect blood marker. Such a test could spare patients from invasive lumbar punctures, broaden care access, and allow AD cases to ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain pe ...